Depakene Related Published Studies
Well-designed clinical trials related to Depakene (Valproic Acid)
Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial. [2009.09]
Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis. [2009.08]
Effects of valproic acid on sleep in children with epilepsy. [2009.08]
Lamotrigine and valproic acid have different effects on motorcortical neuronal excitability. [2009.04]
Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial. [2008.06.26]
Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. [2007.11]
Lack of Pharmacokinetic Interaction of Levetiracetam on Carbamazepine, Valproic Acid, Topiramate, and Lamotrigine in Children with Epilepsy. [2007.07.25]
Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report. [2006.03.28]
Every-12-hour administration of extended-release divalproex in patients with epilepsy: impact on plasma valproic acid concentrations. [2006.03]
Lower effectiveness of divalproex versus valproic acid in a prospective, quasi-experimental clinical trial involving 9,260 psychiatric admissions. [2005.02]
Quality of life assessment in patients with bipolar disorder treated with olanzapine added to lithium or valproic acid. [2004.09]
Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study. [2004.09]
Treatment of idiopathic restless legs syndrome (RLS) with slow-release valproic acid compared with slow-release levodopa/benserazid. [2004.05]
Valproic acid has no effect on pain in polyneuropathy: a randomized, controlled trial. [2004.01.27]
Valproic acid for agitation in dementia. [2004]
Valproic acid for the treatment of social anxiety disorder. [2003.05]
Lack of pharmacokinetic interaction between valproic acid and a traditional Chinese medicine, Paeoniae Radix, in healthy volunteers. [2000.12]
Influence of Ramadan on the pharmacokinetics of a single oral dose of valproic acid administered at two different times. [2000.03]
The efficacy of felbamate as add-on therapy to valproic acid in the Lennox-Gastaut syndrome. [1999.04]
Effects of switching from Depakene to generic valproic acid on individuals with mental retardation. [1997.12]
Lack of kinetic interaction between valproic acid and citrus pectin. [1997.10]
Pharmacokinetics of valproic acid in patients with juvenile myoclonic epilepsy on monotherapy. [1997.04]
Acute effects of bromocriptine, cyproheptadine, and valproic acid on plasma adrenocorticotropin secretion in Nelson's syndrome. [1997.02]
Valproic acid treatment of learning disorder and severely epileptiform EEG without clinical seizures. [1996.01]
Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of beta-oxidation. [1996.01]
Relative bioavailability of different valproic acid formulations. [1995.12]
The effect of felbamate on valproic acid disposition. [1994.11]
The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid. [1993.10]
Pharmacokinetic comparison of two valproic acid formulations--a plain and a controlled release enteric-coated tablets. [1993.08]
Synergy of carbamazepine and valproic acid in affective illness: case report and review of the literature. [1992.08]
Intermittent prophylaxis in febrile convulsions: diazepam or valproic acid? [1990.07]
Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid. [1989.05]
Well-designed clinical trials possibly related to Depakene (Valproic Acid)
Valproate preparations for agitation in dementia. [2009.07.08]
Valproate treatment and cocaine cue reactivity in cocaine dependent individuals. [2009.06.01]
A double-blind randomized trial of mood stabilizer augmentation using lamotrigine and valproate for patients with schizophrenia who are stabilized and partially responsive. [2009.06]
A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents. [2009.05]
Lamotrigine and valproate pharmacokinetics interactions in epileptic patients. [2009.04]
A preliminary controlled trial of divalproex in posttraumatic stress disorder. [2009.04]
Effects of valproate or lamotrigine monotherapy on the reproductive endocrine and insulin-related metabolic profile in Chinese adults with epilepsy: a prospective randomized study. [2009.04]
Comparative efficacy and safety of oxcarbazepine versus divalproex sodium in the treatment of acute mania: a pilot study. [2009.04]
Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). [2009.04]
Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia. [2009.04]
A limited number of 5-azacitidine cycles can be effective treatment in MDS. [2009.03]
Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study. [2009.03]
Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: a prospective double-blind randomized placebo-controlled study. [2009.03]
Comparison of add-on valproate and primidone in carbamazepine-unresponsive patients with partial epilepsy. [2009.03]
A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence. [2009.01]
Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-label safety study. [2009.01]
A pilot pharmacotherapy trial for depressed youths at high genetic risk for bipolarity. [2008.12]
Comparison of the effectiveness of topiramate and sodium valproate in pediatric migraine. [2008.12]
Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study. [2008.11]
Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate. [2008.10]
Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study. [2008.10]
A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode. [2008.09]
A limited number of 5-azacitidine cycles can be effective treatment in MDS. [2008.08.12]
Hyperandrogenism, ovulatory dysfunction, and polycystic ovary syndrome with valproate versus lamotrigine. [2008.08]
Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). [2008.08]
Valproate treatment of acute alcohol hallucinosis: a double-blind, placebo-controlled study. [2008.07]
Attention changes in epilepsy patients following 3-month topiramate or valproate treatment revealed by event-related potential. [2008.06]
Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months. [2008.05.27]
Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate. [2008.04]
Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder. [2008.04]
Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate. [2008.04]
Valproate-induced thrombocytopenia: a prospective monotherapy study. [2008.03]
Valproate (depakine-chrono) in the acute treatment of outpatients with generalized anxiety disorder without psychiatric comorbidity: randomized, double-blind placebo-controlled study. [2008.03]
Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. [2008.02]
The effect of sodium valproate on chronic daily headache and its subgroups. [2008.02]
Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine. [2008.02]
Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot study. [2007.12]
The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures. [2007.12]
Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. [2007.12]
Risperidone alone versus risperidone plus valproate in the treatment of patients with schizophrenia and hostility. [2007.11]
Lamotrigine extended-release as adjunctive therapy for partial seizures. [2007.10.16]
Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial. [2007.10]
Subcutaneous histamine versus sodium valproate in migraine prophylaxis: a randomized, controlled, double-blind study. [2007.10]
Divalproex Sodium for the Treatment of PTSD and Conduct Disordered Youth: A Pilot Randomized Controlled Clinical Trial. [2007.10]
Reversible effects of antiepileptic drugs on reproductive endocrine function in men and women with epilepsy--a prospective randomized double-blind withdrawal study. [2007.10]
A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. [2007.10]
Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data. [2007.09]
Randomized study of intravenous valproate and phenytoin in status epilepticus. [2007.09]
Facial emotion processing in acutely ill and euthymic patients with pediatric bipolar disorder. [2007.08]
A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania. [2007.07]
Health-related quality of life and its predictive role for analgesic effect in patients with painful polyneuropathy. [2007.07]
Sodium valproate versus lamotrigine: A randomised comparison of efficacy, tolerability and effects on circulating androgenic hormones in newly diagnosed epilepsy. [2007.07]
The measurement and magnitude of awareness difficulties after traumatic brain injury: a longitudinal study. [2007.07]
Topiramate or valproate in patients with juvenile myoclonic epilepsy: A randomized open-label comparison. [2007.06]
Quetiapine for acute mania in bipolar disorder. [2007.05.15]
Double-blind, placebo-controlled trial of divalproex monotherapy in the treatment of symptomatic youth at high risk for developing bipolar disorder. [2007.05]
Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder. [2007.05]
Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse. [2007.04]
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. [2007.03.24]
Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. [2007.03]
Safety of rapid intravenous valproate infusion in pediatric patients. [2007.02]
Antiepileptic drugs for the treatment of chronic and episodic cluster headache: a review. [2007.01]
A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease. [2007]
A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder. [2007]
Influence of major antiepileptic drugs on attention, reaction time, and speed of information processing: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients receiving monotherapy. [2006.12]
The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s). [2006.12]
Efficacy of carbamazepine and valproate as monotherapy for early epilepsy and single seizures. [2006.11.28]
Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial. [2006.11]
2005 AES Annual Course: Evidence Used to Treat Women with Epilepsy. [2006.10]
|
